Stryker's 2018 Q1 sales spike 9.7% to $3.2B: 5 takeaways

Written by Mackenzie Garrity | April 27, 2018 | Print  |

In the first quarter of 2018, Stryker saw growth in all aspects of its business. The company released its financial results to provide further detail.

Here are five takeaways.

1. Stryker's net sales increased 9.7 percent year-over-year, generating $3.2 billion in sales.

2. In its orthopedics segment, Stryker reported a 7.1 percent increase in sales year-over-year, with 4.7 percent being organic. Net sales totaled $1.2 billion for the quarter.

3. Within the medsurg segment, Stryker reported a 9.3 percent increase in sales year-over-year, with 7.8 percent being organic and 1.3 percent being through acquisitions. Net sales totaled $1.4 billion for the quarter.

4. Stryker's neurotechnology and spine segment experience the largest growth, as expect. The company reported a 16.1 percent increase in sales year-over-year, with 3.4 percent through acquisitions and 10.1 percent organically. Net sales totaled $600 million for the quarter.

5. Based on it's first quarter performance, Stryker expects its second quarter diluted earnings per share to be between $1.70 to $1.75.

More articles on devices and implants:
Jury sides with spine surgeon in case of off-label use of Medtronic's Infuse: 6 things to know
Zimmer Biomet reports a 2.3% jump in sales, spine segment generates $183M: 5 Q1 details
CoreLink appoints David Castleman 1st VP of research and development: 5 things to note

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months